The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients.

ABSTRACT:

Background

We conducted a meta-analysis to provide evidence-based results for the predictive values of sarcopenia, skeletal muscle index, psoas muscle index and the myosteatosis regarding the impact of survival outcomes and tumor response in patients treated by trans-arterial (chemo)-embolization (TAE/TACE), thereby optimizing therapeutic strategies and maximizing clinical benefits for hepatocellular carcinoma patients.

Methods

Qualified studies were retrieved from PubMed, the Cochrane Library, EMBASE, and Google Scholar before June 19, 2023. We investigated the relationships between sarcopenia, SMI, PMI, myosteatosis, and the overall survival of TAE/TACE-treated hepatocellular carcinoma patients with pooling data.

Results

A total of 167 studies were collected and 12

SUBMITTER: Long J 

PROVIDER: S-EPMC10817392 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature